Indeed, T22-PE24-H6 showed in vitro CXCR4-dependent cytotoxicity in human AML cell lines, as shown by the competition assay with AMD3100 and the lack of sensitivity to the nanotoxin in the CXCR4- cell line. The gene discussed is CXCR4; the disease is acute myeloid leukemia.